Biovaxys Technology Corp Stock Probability of Future OTC Stock Price Finishing Over 0.0494
| BVAXF Stock | USD 0.05 0.01 11.78% |
Biovaxys |
Biovaxys Technology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biovaxys Technology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biovaxys Technology Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biovaxys Technology had very high historical volatility over the last 90 days | |
| Biovaxys Technology has some characteristics of a very speculative penny stock | |
| Biovaxys Technology has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biovaxys Technology until it has trouble settling it off, either with new capital or with free cash flow. So, Biovaxys Technology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biovaxys Technology Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biovaxys to invest in growth at high rates of return. When we think about Biovaxys Technology's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biovaxys Technology Corp has accumulated about 39.05 K in cash with (5.29 M) of positive cash flow from operations. | |
| Roughly 19.0% of the company shares are held by company insiders |
Biovaxys Technology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biovaxys OTC Stock often depends not only on the future outlook of the current and potential Biovaxys Technology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biovaxys Technology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 92.2 M |
Biovaxys Technology Technical Analysis
Biovaxys Technology's future price can be derived by breaking down and analyzing its technical indicators over time. Biovaxys OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biovaxys Technology Corp. In general, you should focus on analyzing Biovaxys OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Biovaxys Technology Predictive Forecast Models
Biovaxys Technology's time-series forecasting models is one of many Biovaxys Technology's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biovaxys Technology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Biovaxys Technology Corp
Checking the ongoing alerts about Biovaxys Technology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biovaxys Technology Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biovaxys Technology had very high historical volatility over the last 90 days | |
| Biovaxys Technology has some characteristics of a very speculative penny stock | |
| Biovaxys Technology has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biovaxys Technology until it has trouble settling it off, either with new capital or with free cash flow. So, Biovaxys Technology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biovaxys Technology Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biovaxys to invest in growth at high rates of return. When we think about Biovaxys Technology's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biovaxys Technology Corp has accumulated about 39.05 K in cash with (5.29 M) of positive cash flow from operations. | |
| Roughly 19.0% of the company shares are held by company insiders |
Other Information on Investing in Biovaxys OTC Stock
Biovaxys Technology financial ratios help investors to determine whether Biovaxys OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biovaxys with respect to the benefits of owning Biovaxys Technology security.